Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

It's beginning to look a lot like Gutmas!

Congratulations to Vy Wien Lai, whose image was chosen for 1st place in the MRC/MRF 2025 Festive Science Image Competition.

Battle in the Gut at IF Oxford 2025

In October 2025, researchers from the MRC Translational Immune Discovery Unit led activities on researching gut bacteria at Oxford Science + Ideas Festival.

Study reveals how drug resistance develops early in targeted AML therapy

A new study led by researchers at the MRC Molecular Haematology Unit has shown that resistance to a targeted treatment for acute myeloid leukaemia (AML) can develop much earlier than expected.

Iron supplement absorption preserved in children with HIV and boosted by prebiotics

New research shows that iron from supplements and fortified foods is well-absorbed in children living with virally suppressed HIV, and that administering iron supplements with prebiotics may enhance their effectiveness and improve their safety.

Oxford scientists map the cells that drive Crohn’s disease fistulas

Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn’s disease - paving the way for targeted treatments.

Oxford scientists capture genome’s structure in unprecedented detail

RDM scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.

Abdullah Khan receives Wellcome Career Development Award

Congratulations are in order for Dr Abdullah (Abs) Khan, who has been awarded a Wellcome Career Development Award for his research on age-related immune dysfunction using human model systems.

Unravelling T-Cell Recognition: Insights from Immunology and AI

From 29 September to 1 October 2025, researchers from across the world gathered in Oxford for a unique conference and hackathon exploring how advances in artificial intelligence can deepen understanding of T-cell biology.

New study finds link between mild COVID-19 disease and certain T cell responses

The study, led by researchers at the MRC Translational Immune Discovery Unit and the CAMS Oxford Institute (NDM), found that dominant T cell responses found in many individuals 4 years after infection are associated with mild COVID-19 disease, and likely play important protective roles in subsequent viral infection events.

MRC WIMM researchers receive full Professor title

James Davies and Bethan Psaila have been awarded the title of Full Professor in the University’s 2025 Recognition of Distinction exercise.

Researching Iron: from Molecules to Global Health

Iron deficiency is the world’s most common nutritional deficiency, affecting an estimated two billion people worldwide. The Drakesmith Group is collaborating with researchers across the University and internationally to tackle this problem from multiple angles.

Hashem Koohy receives Wellcome Discovery Award to decode T cell immunity

Hashem Koohy, Associate Professor of Systems Immunology, has been awarded funding from Wellcome to develop computational strategies to decipher the underlying rules of adaptive T cell immunity.

Body-in-a-chip approach reveals how immune cells respond to heart injury

Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.

New ‘off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukaemia

Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukaemia.

The Kaiya Foundation to fund leukaemia research at University of Oxford

The foundation has awarded one of its first major research grants to Dr Emily Neil and Professor Anindita Roy from the Childhood Leukaemia Research Group in the MRC Molecular Haematology Unit.

Load More